%0 Journal Article
%T A Network Meta-analysis Comparing the Efficacy and Safety of Anti-PD-1 with Anti-PD-L1 in Non-small Cell Lung Cancer
%A Dian-Kun Cai
%A Hao Peng
%A Ji-Dong Miao
%A Mei Liu
%A Wei You
%A Yang Gao
%A Yi-Bing Song
%A Yu-Qian Liao
%J Journal of Cancer
%D 2018
%I Ivyspring International Publisher
%R 10.7150/jca.22361
%X Background: This network meta-analysis aimed at comparing anti-programmed death 1 (anti-PD-1) with anti-programmed death ligand 1(anti-PD-L1) immunotherapy in patients with metastatic, previously treated non-small cell lung cancer (NSCLC) who failed first-line treatment.
%K Non-small cell lung cancer
%K PD-1
%K PD-L1
%K immunotherapy
%K Nivolumab.
%U http://www.jcancer.org/v09p1200.htm